Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Ann Thorac Surg. 2018 Nov 17;107(5):1571–1581. doi: 10.1016/j.athoracsur.2018.10.016

Fig 4.

Fig 4.

Mortality, thromboembolic events, and major bleeding complications at 3 to 6 months in trials that compared acetylsalicylic acid (ASA) versus dual antiplatelet therapy (DAPT) after transcatheter aortic valve replacement. (CI = confidence interval; M-H = Mantel-Haenszel.)